Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Receives Average Rating of "Buy" from Brokerages

Retrieved on: 2021-03-01 13:52:30

Tags for this article:

Click the tags to see associated articles and topics

Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) Receives Average Rating of "Buy" from Brokerages. View article details on hiswai:

Excerpt

Schonfeld Strategic Advisors LLC acquired a new position in Arena Pharmaceuticals in the 3rd quarter valued at about $1,286,000. Emerald Advisers ...

Article found on: www.marketbeat.com